Evidence map›Paper›PMID 37626214›Full record

Trial reportInternational journal of legal medicine2023

Effect of vaporizing cannabis rich in cannabidiol on cannabinoid levels in blood and on driving ability - a randomized clinical trial.

Laura Egloff, Priska Frei, Kathrin Gerlach, Katja Mercer-Chalmers-Bender, Eva Scheurer

Open access · hybridAbstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in International journal of legal medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Laura EgloffInstitute of Forensic Medicine, Department of Biomedical Engineering, University of Basel, Pestalozzistrasse 22, 4056, Basel, Switzerland.ORCID http://orcid.org/0000-0001-7809-7541
Priska FreiInstitute of Forensic Medicine, Department of Biomedical Engineering, University of Basel, Pestalozzistrasse 22, 4056, Basel, Switzerland.ORCID http://orcid.org/0000-0003-2408-1901
Kathrin GerlachInstitute of Forensic Medicine, Department of Biomedical Engineering, University of Basel, Pestalozzistrasse 22, 4056, Basel, Switzerland.ORCID http://orcid.org/0000-0002-9007-434X
Katja Mercer-Chalmers-BenderInstitute of Forensic Medicine, Department of Biomedical Engineering, University of Basel, Pestalozzistrasse 22, 4056, Basel, Switzerland.ORCID http://orcid.org/0000-0002-3843-9065
Eva ScheurerInstitute of Forensic Medicine, Department of Biomedical Engineering, University of Basel, Pestalozzistrasse 22, 4056, Basel, Switzerland. eva.scheurer@unibas.ch.ORCID http://orcid.org/0000-0002-2742-0422
University of Basel · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this prospective, placebo-controlled, double-blind, randomized, cross-over study was to determine cannabinoid levels in blood and driving-related ability after single (S1) and repetitive (S2) vaporization of cannabis rich in cannabidiol (CBD) containing < 1% Δ

Indexed as

CannabidiolCannabisCross-Over StudiesAdultAutomobile DrivingCannabinoidsDouble-Blind MethodDriving Under the InfluenceDronabinolFemaleHumansMaleProspective StudiesVolatilizationYoung AdultCannabidiolCannabinoidsDronabinolCannabidiolCognitionDriving abilityRoad safetyΔ9- tetrahydrocannabinol

Identifiers

PMID37626214
PMCPMC10567805
OpenAlexW4386158164

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.